← FDA Drug Approvals (Drugs@FDA)

OJEMDA

NDA · New Drug Application · Sponsor: DAY ONE BIOPHARMS · Approved 2024-04-23

Drug application

FDA Application #

NDA218033

Application type

New Drug Application

Brand name

OJEMDA

Generic name

TOVORAFENIB

Active ingredients

TOVORAFENIB

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

DAY ONE BIOPHARMS

Manufacturer

Day One Biopharmaceuticals, Inc.

First approval

2024-04-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown